메뉴 건너뛰기




Volumn 104, Issue 7, 2011, Pages 1238-1239

Severe hypertriglyceridaemia during treatment with capecitabine

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CHOLESTEROL; FENOFIBRATE; FULVESTRANT; PACLITAXEL; PRAVASTATIN; ROSUVASTATIN; TRIACYLGLYCEROL;

EID: 79953188671     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.52     Document Type: Letter
Times cited : (19)

References (6)
  • 2
    • 33144461290 scopus 로고    scopus 로고
    • Capecitabine-induced severe hypertriglyceridemia: Report of two cases
    • DOI 10.1345/aph.1G348
    • Kurt M, Babaoglu O, Yasar U, Shorbagi A, Guler N (2006) Capecitabine-induced severe hypertriglyceridemia: report of two cases. Ann Pharmaco-ther 40: 328-331 (Pubitemid 43269867)
    • (2006) Annals of Pharmacotherapy , vol.40 , Issue.2 , pp. 328-331
    • Kurt, M.1    Babaoglu, M.O.2    Yasar, U.3    Shorbagi, A.4    Guler, N.5
  • 3
    • 77955985007 scopus 로고    scopus 로고
    • The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: A prospective study
    • Michie CO, Sakala M, Rivans I, Strachan MWJ, Clive S (2010) The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study. Br J Cancer 103: 617-621
    • (2010) Br J Cancer , vol.103 , pp. 617-621
    • Michie, C.O.1    Sakala, M.2    Rivans, I.3    Mwj, S.4    Clive, S.5
  • 5
    • 77950804513 scopus 로고    scopus 로고
    • Trifluorothymidine resistance is associated with decreased thymidine kinase and equilibrative nucleotide transporter expression or increased secretory phospholipase A2
    • Temmink OH, Bijnsdorp IV, Prins HJ, Losekoot N, Adema AD, Smid K, Honeywell RJ, Ylstra B, Ejik PP, Fukushima M, Peters GJ (2010) Trifluorothymidine resistance is associated with decreased thymidine kinase and equilibrative nucleotide transporter expression or increased secretory phospholipase A2. Mol Cancer Ther 9: 1047-1057
    • (2010) Mol Cancer Ther , vol.9 , pp. 1047-1057
    • Temmink, O.H.1    Bijnsdorp, I.V.2    Prins, H.J.3    Losekoot, N.4    Adema, A.D.5    Smid, K.6    Honeywell, R.J.7    Ylstra, B.8    Ejik, P.P.9    Fukushima, M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.